Global Allergy Immunotherapy Market Size & Outlook

The global allergy immunotherapy market size was estimated at USD 1,922.7 million in 2024 and is projected to reach USD 3,193.3 million by 2030, growing at a CAGR of 8.7% from 2025 to 2030.
Revenue, 2024 (US$M)
$1,922.7
Forecast, 2030 (US$M)
$3,193.3
CAGR, 2025 - 2030
8.7%
Report Coverage
Worldwide

Global allergy immunotherapy market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global allergy immunotherapy market highlights

  • The global allergy immunotherapy market generated a revenue of USD 1,922.7 million in 2024 and is expected to reach USD 3,193.3 million by 2030.
  • The market is expected to grow at a CAGR (2025 - 2030) of 8.7% by 2030.
  • In terms of segment, subcutaneous immunotherapy accounted for a revenue of USD 1,394.9 million in 2024.
  • Sublingual immunotherapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.
  • In terms of region, Europe was the largest revenue generating market in 2024.
  • Country-wise, China is expected to register the highest CAGR from 2025 to 2030.

Global data book summary

Market revenue in 2024USD 1,922.7 million
Market revenue in 2030USD 3,193.3 million
Growth rate8.7% (CAGR from 2025 to 2030)
Largest segmentSubcutaneous immunotherapy
Fastest growing segmentSublingual immunotherapy
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSubcutaneous immunotherapy, Sublingual immunotherapy

Other key industry trends

  • In terms of revenue, the North America accounted for 19.8% of the global allergy immunotherapy market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, China is the fastest growing regional market and is projected to reach USD 74.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Allergy Immunotherapy Market Companies

Name Profile # Employees HQ Website
Stallergenes Greer View profile 1001-5000 London, England, United Kingdom, Europe http://stallergenesgreer.com/
DMK Pharmaceuticals Corp View profile 12 11682 El Camino Real, Suite 300, San Diego, CA, United States, 92130 https://www.adamispharmaceuticals.com
HollisterStier Allergy View profile 251-500 Spokane, Washington, United States, North America https://www.hsallergy.com
HAL Allergy Group View profile 251-500 Leiden, Zuid-Holland, The Netherlands, Europe https://www.hal-allergy.com/
Desentum View profile 1-10 Espoo, Southern Finland, Finland, Europe http://www.desentum.fi/en/
Circassia View profile 51-100 Oxford, Oxfordshire, United Kingdom, Europe http://www.circassia.com/
ASIT biotech View profile 11-50 Brunelles, Centre, France, Europe https://www.asitbiotech.com/
Alk-Abello A/S Class B View profile 2828 Boge Alle 6-8, Horsholm, Denmark, DK-2970 https://www.alk.net
Mylan View profile 10001+ https://www.mylan.in/
Allergy Therapeutics PLC View profile 612 Dominion Way, Worthing, West Sussex, United Kingdom, BN14 8SA https://www.allergytherapeutics.com
DBV Technologies SA ADR View profile 105 177-181 avenue Pierre Brossolette, Montrouge, France, 92120 http://www.dbvtechnologies.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

Global allergy immunotherapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to allergy immunotherapy market will help companies and investors design strategic landscapes.


Subcutaneous immunotherapy was the largest segment with a revenue share of 72.55% in 2024. Horizon Databook has segmented the Global allergy immunotherapy market based on subcutaneous immunotherapy, sublingual immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Allergy Immunotherapy Treatment Type Outlook (Revenue, USD Million, 2018-2030)
    • Subcutaneous immunotherapy
    • Sublingual immunotherapy
      • Tablets
      • Drops
  • Global Allergy Immunotherapy Allergy Type Outlook (Revenue, USD Million, 2018-2030)
    • Allergic Rhinitis
    • Allergic Asthma
    • Other Allergies
  • Global Allergy Immunotherapy Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Reasons to subscribe to Global allergy immunotherapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global allergy immunotherapy market databook

  • Our clientele includes a mix of allergy immunotherapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global allergy immunotherapy market, including forecasts for subscribers. This global databook contains high-level insights into Global allergy immunotherapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global allergy immunotherapy market size, by regions, 2018-2030 (US$M)

Top 10 countries: Allergy immunotherapy market size, 2024 (US$M)

Global allergy immunotherapy market share, by treatment type, 2024 & 2030 (%, US$M)

Allergy immunotherapy market: Opportunity assessment by country

Global allergy immunotherapy market, by region, 2024 (US$M)

Global allergy immunotherapy market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online